Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer

BackgroundWhether radiotherapy can improve the long-term survival of HER-2+ metastatic breast cancer remains unclear. We launched this study to explore the effect of HER-2+ metastatic breast cancer patients through anti-HER-2 targeted therapy + radiotherapy.Methods488 HER-2 + metastatic breast cance...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xueting Li, Xiaorong Zhong, Hongyu Xu, Jun Wang, Xianguo Liu, Yang Wang, Liang He, Jiayu Ma, Guanghua Li, Lei Liu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-01-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	radiotherapy HER-2 breast cancer overall survival targeted therapy for metastatic breast cancer
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1305429/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!